Galectin Therapeutics reported $117.1M in Market Capitalization this March of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US USD 285.8B 48.51B
Bristol Myers Squibb BMY:US USD 152.98B 1.18B
Galectin Therapeutics GALT:US USD 97M 19M
Gilead Sciences GILD:US USD 107.68B 30.32B
Idera Pharmaceuticals IDRA:US USD 23M 1000K
Intercept Pharmaceuticals ICPT:US USD 512M 62M
Merk MRK:US USD 281.3B 63.14B
Regulus Therapeutics RGLS:US USD 23M 2M
Vital Therapies VTL:US USD 62M 35M
YTE INCY:US USD 17.87B 3.05B